title: Effects of 5-hydroxymethyl-2-furfural on the volume and membrane permeability of red blood cells from patients with sickle cell disease.
abstract: The heterocyclic aldehyde 5-hydroxymethyl-2-furfural (5HMF) interacts allosterically with the abnormal form of haemoglobin (Hb), HbS, in red blood cells (RBCs) from patients with sickle cell disease (SCD), thereby increasing oxygen affinity and decreasing HbS polymerization and RBC sickling during hypoxia. We hypothesized that should 5HMF also inhibit the main cation pathways implicated in the dehydration of RBCs from SCD patients - the deoxygenation-induced cation pathway (Psickle), the Ca(2+)-activated K(+) channel (the Gardos channel) and the K(+)-Cl(-) cotransporter (KCC) - it would have a synergistic effect in protection against sickling, directly through interacting with HbS, and indirectly through maintaining hydration and reducing [HbS]. This study was therefore designed to investigate the effects of 5HMF on RBC volume and K(+) permeability in vitro. 5HMF markedly reduced the deoxygenation-induced dehydration of RBCs whether in response to maintained deoxygenation or to cyclical deoxygenation/re-oxygenation. 5HMF was found to inhibit Psickle, an effect which correlated with its effects on sickling. Deoxygenation-induced activation of the Gardos channel and exposure of phosphatidylserine were also inhibited, probably indirectly via reduced entry of Ca(2+) through the Psickle pathway. Effects of 5HMF on KCC were more modest with a slight inhibition in N-ethylmaleimide (NEM, 1 mm)-treated RBCs and stimulation in RBCs untreated with NEM. These findings support the hypothesis that 5HMF may also be beneficial through effects on RBC ion and water homeostasis.
authors.affiliation: Department of Veterinary Medicine, University of Cambridge, Cambridge, UK.
authors.forename: Anke
authors.initials: A
authors.lastname: Hannemann
authors.affiliation: Department of Veterinary Medicine, University of Cambridge, Cambridge, UK.
authors.forename: Urszula M
authors.initials: UM
authors.lastname: Cytlak
authors.affiliation: Department of Paediatric Haematology, King's College London School of Medicine, King's College Hospital NHS Foundation Trust, London, UK.
authors.forename: David C
authors.initials: DC
authors.lastname: Rees
authors.affiliation: Department of Paediatric Haematology, King's College London School of Medicine, King's College Hospital NHS Foundation Trust, London, UK.
authors.forename: Sanjay
authors.initials: S
authors.lastname: Tewari
authors.affiliation: Department of Veterinary Medicine, University of Cambridge, Cambridge, UK jsg1001@cam.ac.uk.
authors.forename: John S
authors.initials: JS
authors.lastname: Gibson
mesh_terms: D000755:Anemia, Sickle Cell / Q000097:blood*; D002118:Calcium / Q000378:metabolism; D002462:Cell Membrane / Q000187:drug effects* / Q000378:metabolism; D048429:Cell Size; D002478:Cells, Cultured; D004912:Erythrocytes / Q000187:drug effects* / Q000378:metabolism; D005662:Furaldehyde / Q000031:analogs & derivatives* / Q000494:pharmacology; D006801:Humans; D051660:Intermediate-Conductance Calcium-Activated Potassium Channels / Q000378:metabolism; D010539:Permeability; D010718:Phosphatidylserines / Q000378:metabolism; D011188:Potassium / Q000378:metabolism; D027981:Symporters / Q000378:metabolism; D000096922:K Cl- Cotransporters
chemical_list: D002118:Calcium; D005662:Furaldehyde; D051660:Intermediate-Conductance Calcium-Activated Potassium Channels; D010718:Phosphatidylserines; D011188:Potassium; D027981:Symporters; D000096922:K Cl- Cotransporters; C496923:KCNN4 protein, human; C008046:5-hydroxymethylfurfural